Effect of complementary feeding with lipid-based nutrient supplements and corn-soy blend on the incidence of stunting and linear growth among 6- to 18-month-old infants and children in rural Malawi

Matern Child Nutr. 2015 Dec;11 Suppl 4(Suppl 4):132-43. doi: 10.1111/mcn.12068.

Abstract

Low nutritional value of complementary foods is associated with high incidence of childhood growth stunting in low-income countries. This study was done to test a hypothesis that dietary complementation with lipid-based nutrient supplements (LNS) promotes linear growth and reduces the incidence of severe stunting among at-risk infants. A total of 840 6-month-old healthy infants in rural Malawi were enrolled to a randomised assessor-blinded trial. The participants received 12-month supplementation with nothing, milk-LNS, soy-LNS, or corn-soy blend (CSB). Supplements provided micronutrients and approximately 280 kcal energy per day. Outcomes were incidence of severe and very severe stunting [length-for-age z-score, (LAZ) < -3.00 and <-3.50, respectively], and change in LAZ. The incidence of severe stunting was 11.8%, 8.2%, 9.1% and 15.5% (P = 0.098) and that of very severe stunting 7.4%, 2.9%, 8.0% and 6.4% (P = 0.138) in control, milk-LNS, soy-LNS and CSB groups, respectively. Between 9 and 12 months of age, the mean change in LAZ was -0.15, -0.02, -0.12 and -0.18 (P = 0.045) for control, milk-LNS, soy-LNS and CSB groups, respectively. There was no significant between-group difference in linear growth during other age-intervals. Although participants who received milk-LNS had the lowest incidence of severe and very severe stunting, the differences between the groups were smaller than expected. Thus, the results do not provide conclusive evidence on a causal association between the LNS supplementation and the lower incidence of stunting. Exploratory analyses suggest that provision of milk-LNS, but not soy-LNS promotes linear growth among at-risk infants mainly between 9 and 12 months of age.

Keywords: children; complementary feeding; infants; linear growth; lipid-based nutrient supplements; stunting.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Child Development / physiology
  • Dietary Carbohydrates / administration & dosage
  • Dietary Carbohydrates / analysis
  • Dietary Fats / administration & dosage*
  • Dietary Proteins / administration & dosage
  • Dietary Proteins / analysis
  • Dietary Supplements*
  • Energy Intake
  • Follow-Up Studies
  • Glycine max
  • Growth Disorders / diet therapy
  • Growth Disorders / epidemiology*
  • Humans
  • Incidence
  • Infant
  • Infant Formula / chemistry*
  • Infant Nutritional Physiological Phenomena*
  • Malawi / epidemiology
  • Malnutrition / diet therapy
  • Malnutrition / epidemiology*
  • Micronutrients / administration & dosage
  • Micronutrients / analysis
  • Milk
  • Nutritive Value
  • Rural Population
  • Treatment Outcome
  • Zea mays

Substances

  • Dietary Carbohydrates
  • Dietary Fats
  • Dietary Proteins
  • Micronutrients